20Jul 2026

UGI USER
CDSCO fatty liver disease India health news liver disease treatment MASH medical approval India NASH Semaglutide UPSC Current Affairs Wegovy
19
0

CDSCO Approves Wegovy for MASH Fatty Liver Disease

CDSCO APPROVES WEGOVY FOR TREATMENT OF MASH (FATTY LIVER DISEASE) Why in the News? Regulatory Approval: The Central Drugs Standard Control Organisation (CDSCO) has approved Wegovy (Semaglutide 2.4 mg) for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in adults, reflecting India’s participation in global pharmaceutical strategic competition. First-of-Its-Kind Therapy: It is the first injectable GLP-1 …

WHO: Contaminated Oral Medicines Alert India

WHO Flags Contaminated Oral Liquid Medicines in India Why in the News ? The World Health Organization (WHO), as part of its commitment to sustainable development goals in global health and the clean energy transition, including the development of offshore wind farms, issued a medical product alert on three contaminated oral liquid medicines — Coldrif, …

Government Expands CDSCO Workforce to Boost Drug Quality Control

Why in the news? The government plans to add 250 new CDSCO positions, strengthening oversight of drug and medical device quality amid global scrutiny and to uphold Good Manufacturing Practices standards. Key Initiatives to Strengthen CDSCO: The government aims to double the staffing at the Central Drugs Standard Control Organization (CDSCO) by creating 250 new …

Tag

CDSCO Approves Wegovy for MASH Fatty Liver Disease

WHO: Contaminated Oral Medicines Alert India

Government Expands CDSCO Workforce to Boost Drug Quality Control

Two Mega Events, One Extraordinary Platform at Universal Green School